EMA Approves New Levodopa-Carbidopa Formulation for Parkinson’s Motor Fluctuations
The European Medicines Agency (EMA) has authorized a new dual-release formulation of levodopa-carbidopa to treat motor fluctuations in patients with Parkinson’s disease. By combining immediate-release and extended-release components, this therapy ... Read More